Applications Accepted Until April 3
Scope Expanded to Include Soft Extracts in Addition to Decoctions and Pills

The National Institute for Korean Medicine Development is recruiting participating institutions nationwide for the "Prescribed Herbal Medicine Quality Monitoring Program," targeting external herbal medicine preparation facilities.


This program, which is being implemented to ensure the quality and safety of prescribed herbal medicine and to establish a hygienic preparation environment, has been operated with support from the Ministry of Health and Welfare since 2019.

Partial poster recruiting participating institutions for the 2026 Herbal Medicine Dispensing Monitoring.

Partial poster recruiting participating institutions for the 2026 Herbal Medicine Dispensing Monitoring.

View original image

Last year, 33 herbal medicine preparation facilities participated, and a total of 529 monitoring cases were conducted.


This year, the scope of monitoring will be expanded to include not only existing decoctions and pills, but also soft extracts (concentrates).


The inspections will be conducted by the National Institute for Korean Medicine Development’s Quality Certification Center, which will carry out detailed analyses of major safety items such as residual pesticides, heavy metals, mycotoxins, and microbial limits.


Participating institutions can receive monitoring services free of charge.


After the monitoring, a result report and participation certificate will be provided, and safety management consulting will also be supported.


The application period is from March 25 to April 3, and details including the application process and selection criteria can be found on the National Institute for Korean Medicine Development's website.



Ahn Byeonggwan, Head of the Quality Certification Center at the National Institute for Korean Medicine Development, stated, "Through continuous quality monitoring, we will ensure the safety of prescribed herbal medicine and strengthen on-site management capabilities, thereby creating an environment where the public can take these medicines with confidence."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing